Disclosure Code

Disclosure Code

Disclosure Code is a self-regulation of the innovative pharmaceutical companies associated in INFARMA. It defines the rules for providing information on cooperation between signatory companies and medical profession representatives and healthcare organisations.

Code of Good Practices

Code of Good Practices

Maintaining high ethical standards, in 2008 the innovative pharmaceutical industry adopted the Code of Good Practices for the Pharmaceutical Industry.

The Disciplinary Court

The Disciplinary Court

The Disciplinary Court, in accordance with the provisions of the Articles of Association of the Employers' Union of Innovative Pharmaceutical Companies INFARMA, supervises the compliance of the members of the association with the provisions of the Articles of Association, resolutions of the Association governing bodies, or the applicable rules of marketing ethics, including those of the Code of Good Practices of the Pharmaceutical Industry and the Disclosure Code.

The principles for conducting clinical trials

The principles for conducting clinical trials

In October 2010, INFARMA and the Association for Good Clinical Practices in Poland adopted the document "The Principles for Conducting Clinical Trials" which is an example of industry self-regulation resulting from the desire to act in accordance with transparent rules. It defines the standards for the organization of financing and the reporting of clinical trials.

2020 © Copyright: Związek Pracodawców Innowacyjnych Firm Farmaceutycznych INFARMA
All Rights Reserved. Wszelkie prawa zastrzeżone.
Made by Raz Dwa Projekt
page: 0,8237 s, time: 0,8951 s database, query: 260, querytime: 0,0713 s